Official Title
Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU
Brief Summary

The main objective of the study is to determine the incidence of deep vein thromboses at Doppler echo in patients with SARS-Cov-2 pneumopathy upon their entry into ICU and after 7 days of hospitalization in ICU. This is a monocentric interventional study (RIPH 2).

Completed
Deep Vein Thrombosis

Other: Doppler Echo

2 doppler echo will be done at patients hospitalized in ICU and with SARS-CoV-2 pneumopathy at 7 days apart

Eligibility Criteria

Inclusion Criteria:

- Patient > or =18 years

- Hospitalization in intensive care

- PCR COVID 19+ or compatible clinical signs (fever, cough, myalgia, asthenia, loss of
taste, anosmia) associated with compatible radiological signs

Exclusion Criteria:

- Pregnancy in progress

- Patient <18 years

- Patients deprived of freedoms or under guardianship

- Patient or family opponent of protocol participation

- patient on curative anticoagulant for more than 48H00

- impossible Venous Doppler Echo

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

Centre Hospitalier de Versailles
Le Chesnay, France

Versailles Hospital
NCT Number
Keywords
Deep Vein Thrombosis
doppler echo
SARS-CoV-2
ICU
MeSH Terms
Thrombosis
Venous Thrombosis